New Key Statistics Module, Z-Score and F-Score
NYSE:DNA Key Ratios
| Market Cap $ M | 1,136.82 |
| Enterprise Value $ M | 610.26 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.21 |
| Price/Sales | 5.14 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 208.00 |
| EPS (TTM) $ | -0.44 |
| Beneish M-Score | -4.54 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.71 |
| EV-to-EBITDA | -0.77 |
| PEG | -- |
| Shares Outstanding M | 2,211.28 |
| Net Margin (%) | -409.12 |
| Operating Margin % | -350.01 |
| Pre-tax Margin (%) | -409.17 |
| Quick Ratio | 5.34 |
| Current Ratio | 5.34 |
| ROA % (ttm) | -42.76 |
| ROE % (ttm) | -66.20 |
| ROIC % (ttm) | -78.23 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.69 |
DNA Number of Guru Trades
DNA Volume of Guru Trades
Gurus Latest Trades with NYSE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:DNA is held by these investors
Total 2
Ginkgo Bioworks Holdings Inc Insider Transactions
No Available Data
News about NYSE:DNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers